Table 3.
Blood biomarkers related to endocrinology and metabolism.
| Biomarker | ALS | Controls | Finding | Reference |
|---|---|---|---|---|
| Angiogenin | 79 | 72H | High serum level High level in limb versus bulbar onset |
[69] |
| Apolipoprotein E | 403 | 1091ND | Plasma level correlated with progression and survival | [70] |
| CNTF | 36 | 13H 30ND | High serum level | [71] |
| Creatine kinase | 30 | — | High serum level in limb versus bulbar onset | [72] |
| Endoglin | 25 | 25H | Low serum level | [73] |
| IGF | 28 | 28H 41ND | High serum level | [74] |
| IGFBP-1 | 28 | 28H 41ND | Low serum level | [74] |
| LDL/HDL ratio | 286 | 369H | High plasma level Correlated with survival |
[75] |
| N-acetylaspartate | 112 | 51H | High serum level Correlated with progression |
[76] |
| Transglutaminase | 17 | 21ND | Serum activity correlated with disease status | [77] |
H: healthy; ND: neurological/neurodegenerative disease; CNTF: ciliary neurotrophic factor; HDL: high-density lipoprotein; IGF: insulin-like growth factor; IGFBP: insulin-like growth factor binding protein-1; LDL: low-density lipoprotein.